InsidersTradesSigma
Follow the 디알젬 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 디알젬 has published 7 insider filings. The latest transaction was reported on 21 November 2024 (Purchase). Among the most active insiders: 박정병. All data is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
디알젬 is a company listed on the XKRX market, specializing in the healthcare and pharmaceutical sector. It focuses on the development and commercialization of innovative pharmaceutical products.